Loading
Total declarations
Companies
▲ Purchases (24 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Jul 2025 for Oncotelic Therapeutics, Inc., €444.
Filing timeline
BuySaleVuong Trieu
Insider track record
Disclosed buys
24
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
+27.1%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Vuong Trieu: trading record in brief
Filings by Vuong Trieu span 2 companies, the busiest being Oncotelic Therapeutics, Inc. and Marina Biotech, Inc. Between 15 November 2016 and 10 July 2025, the trades on record add up to 32 filings.
On the market, this insider has only ever bought: 24 purchases, €331k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants. Since January 2025: 6 purchases and no sales on the market.
In size, the median ticket on the buying side is €4,061. Clusters matter here: 1 out of 24 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 10 July 2025, reports an open-market purchase of €0 in Oncotelic Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Vuong Trieu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
104,000 shares@ US$0.0050.6% of flowCommon StockSEC:0001641172-25-018620:0
Canonical exit: 8 Oct 2025 (T+90)
183,066 shares@ US$0.0286.8% of flowCommon StockSEC:0001493152-25-004486:0
Canonical exit: 29 Apr 2025 (T+90)
298,499 shares@ US$0.028911.4% of flowCommon StockSEC:0001493152-24-047762:0
Canonical exit: 20 Feb 2025 (T+90)
500,000 shares@ US$0.0212.5% of flowCommon StockSEC:0001493152-24-033939:0
Canonical exit: 21 Nov 2024 (T+90)
425,000 shares@ US$0.02111.4% of flowCommon StockSEC:0001493152-23-023015:0
Canonical exit: 27 Sept 2023 (T+90)
100,000 shares@ US$0.0263.3% of flowCommon StockSEC:0001493152-23-021800:0
Canonical exit: 14 Sept 2023 (T+90)
400,000 shares@ US$0.032616.7% of flowCommon StockSEC:0001493152-23-021563:0
Canonical exit: 12 Sept 2023 (T+90)
126,888 shares@ US$0.03415.6% of flowCommon StockSEC:0001493152-23-019557:0
Canonical exit: 24 Aug 2023 (T+90)
100,000 shares@ US$0.0455.7% of flowCommon StockSEC:0001493152-23-015195:0
Canonical exit: 31 Jul 2023 (T+90)
120,000 shares@ US$0.057.9% of flowCommon StockSEC:0001493152-22-034663:0
Canonical exit: 6 Mar 2023 (T+90)
70,000 shares@ US$0.087.6% of flowCommon StockSEC:0001493152-22-033681:0
Canonical exit: 20 Feb 2023 (T+90)
20,000 shares@ US$0.0682.0% of flowCommon StockSEC:0001493152-22-026963:0
Canonical exit: 25 Dec 2022 (T+90)
80,000 shares@ US$0.0829.1% of flowCommon StockSEC:0001493152-22-024234:0
Canonical exit: 23 Nov 2022 (T+90)
74,455,719 sharesCommon StockSEC:0001493152-21-017106:0
14 of 14 declarations
